secwatch.observer — SEC 8-K summary
======================================

Issuer:     BriaCell Therapeutics Corp. (BCTX)
CIK:        0001610820
Form:       8-K
Filed at:   2026-01-15T23:59:59+00:00
Accession:  0001493152-26-002430
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BriaCell closes $30M public offering of units; warrants trade under BCTXL
-------------------------------------------------------------------------

- Closed public offering of 5,366,726 units at $5.59/unit for gross proceeds of ~$30M.
- Each unit comprises one common share (or pre-funded warrant) and one warrant at $6.93.
- Warrants started trading on Nasdaq on Jan 14 under symbol BCTXL; expire in 5 years.
- Net proceeds to fund working capital, general corporate purposes, and business advancement.
- Placement agent warrants issued to ThinkEquity for 161,001 shares at $8.385 per share.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1610820/000149315226002430/0001493152-26-002430-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1610820/000149315226002430/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-002430

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer